Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noctiva in Nocturia (DB4)
NCT01900704Phase 3Completed
- Sponsor
- Serenity Pharmaceuticals
- Start
- Aug 2013
- Primary completion
- Apr 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desmopressin in nocturia, sponsored by Serenity Pharmaceuticals. Started Aug 2013; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT01900704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01900704.